loading...

Functional Reading Independence Index (FRI Index)

Genentech, Inc.

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed in 2013

Authors

Genentech, Inc.

Copyright
© 2015 Genentech, Inc. All rights reserved.
Objective
To assess reading function in patients with geographic atrophy (GA) from age-related macular degeneration (AMD)
Therapeutic area
  • Eye Diseases
Therapeutic indication

Macular Degeneration

Age-related macular degeneration
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Oestreicher N, Bressler NM, Colman SS et al. The Functional Reading Independence Index (FRII): A New Measure of Treatment Benefit in Geographic Atrophy. Investigative Ophthalmology & Visual Science. 2012 March;53(14):5441-5441 (Conference Abstract)

Kimel M, Yu R, Leidy N. The Functional Reading Independence Index (FRI Index) - User Manual (Version 1.2). Evidera. 2015   

Tschosik E, Leidy NK, Kimel M et al. Quantifying functional reading independence in geographic atrophy: the FRI Index. Investigative Ophthalmology & Visual Science. 2015 June;56(7):4789-4789 (Conference Abstract)

Kimel M, Leidy NK, Tschosik E, Dolan C, Souied EH, Varma R, Bressler NM. Functional Reading Independence (FRI) Index: A New Patient-Reported Outcome Measure for Patients With Geographic Atrophy. Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6298-6304. doi: 10.1167/iovs.16-20361.(PubMed Abstract)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Genentech, Inc.

Betsy Tschosik, RPh, PhD

E-mail: tschosik.elizabeth@gene.com

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. 
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

FRI Index

Arabic for Israel*
Catalan for Spain*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for the UK*
French for Belgium*
French for Canada*
French for France*
French for Switzerland*
German for Austria*
German for Germany*
German for Switzerland*
Greek for Greece*
Hebrew for Israel*
Hungarian for Hungary*
Italian for Italy*
Italian for Switzerland*
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Romanian for Romania*
Russian for Israel*
Russian for Russia*
Slovak for Slovakia*
Spanish for Argentina*
Spanish for Mexico*
Spanish for Peru*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Turkish for Turkey*
* Performed by Mapi

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation:

Not authorized

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us